Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Chelsea Schiliro, Bonnie L. Firestein
Cells (2021) Vol. 10, Iss. 5, pp. 1056-1056
Open Access | Times Cited: 369

Showing 1-25 of 369 citing articles:

Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 976-976
Open Access | Times Cited: 92
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
Tian Li, Tianyun Qiao
Seminars in Cancer Biology (2022) Vol. 86, pp. 117-125
Closed Access | Times Cited: 89
The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment
Chenicheri K. Keerthana, Tennyson P. Rayginia, Sadiq C. Shifana, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 88
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 62
The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells
Martyna Jaworska, Julia Szczudło, Adrian Pietrzyk, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 876-890
Open Access | Times Cited: 58
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 35
The Metabolic Syndrome, a Human Disease
M. Alemany
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2251-2251
Open Access | Times Cited: 29
Anticancer activities of natural antimicrobial peptides from animals
Baozhen Qu, Jiangshui Yuan, Xueli Liu, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 21
Lipid droplets provide metabolic flexibility for cancer progression
Rémi Safi, Pablo Menéndez, Albert Pol
FEBS Letters (2024) Vol. 598, Iss. 10, pp. 1301-1327
Open Access | Times Cited: 17
Nutrient-delivery and metabolism reactivation therapy for melanoma
Yang Chen, Chaochao Wang, Yelin Wu, et al.
Nature Nanotechnology (2024)
Closed Access | Times Cited: 16
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 66
The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities
Noorhan Ghanem, Chirine El‐Baba, Khaled Araji, et al.
Chemotherapy (2021) Vol. 66, Iss. 5-6, pp. 179-191
Open Access | Times Cited: 62
Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis
Charles Allen, Sterling P. Arjona, Maryline Santerre, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 602-602
Open Access | Times Cited: 43
Overview of Cancer Metabolism and Signaling Transduction
Heesuk Chae, Seong‐Tshool Hong
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 12-12
Open Access | Times Cited: 40
Metabolic changes during prostate cancer development and progression
Alicia-Marie K. Beier, Martin Puhr, Matthias B. Stope, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 2259-2270
Open Access | Times Cited: 38
Methyl gallate: Review of pharmacological activity
Huaguo Liang, Qingsong Huang, Li Zou, et al.
Pharmacological Research (2023) Vol. 194, pp. 106849-106849
Open Access | Times Cited: 38
Fasting and fasting mimicking diets in cancer prevention and therapy
Olga Blaževitš, Maira Di Tano, Valter D. Longo
Trends in cancer (2023) Vol. 9, Iss. 3, pp. 212-222
Open Access | Times Cited: 35
The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation
Lilia Alberghina
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15787-15787
Open Access | Times Cited: 33
miRNA-Based Technologies in Cancer Therapy
Maria Pagoni, Claudia Cava, Diamantis C. Sideris, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1586-1586
Open Access | Times Cited: 33
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Elena Puris, Gert Fricker, Mikko Gynther
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 364-364
Open Access | Times Cited: 30
Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression
Yan Zheng, Zhu Le, Zhaoyu Qin, et al.
Cell Reports (2023) Vol. 42, Iss. 7, pp. 112666-112666
Open Access | Times Cited: 29
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
Andrea Cunha, Patrícia Silva, Bruno Sarmento, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2610-2610
Open Access | Times Cited: 24
Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia
Yi Zhang, Zheng Li, Ying Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Targeting the Metabolic Paradigms in Cancer and Diabetes
Mira Bosso, Dania Haddad, Ashraf Al Madhoun, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 211-211
Open Access | Times Cited: 13
Targeting hypoxia signaling pathways in angiogenesis
Sara Monaci, Federica Coppola, Irene Filippi, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top